$WUXI BIO (02269.HK)$ Announced on September 12, 2024, the company plans to repurchase 4.805 million shares at a cost of approximately 55.9992 million Hong Kong dollars, with a repurchase price per share ranging from 11.6 to 11.68 Hong Kong dollars.
药明生物9月12日斥资约5599.92万港元回购480.5万股
Wuxi Bio announced on September 12th that it will spend approximately 55,999.2 million Hong Kong dollars to repurchase 4.805 million shares.
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.